182 related articles for article (PubMed ID: 34331945)
1. Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity.
Aggarwal G; May-Zhang LS; Yermalitsky V; Dikalov S; Voynov MA; Amarnath V; Kon V; Linton MF; Vickers KC; Davies SS
J Biol Chem; 2021 Sep; 297(3):101019. PubMed ID: 34331945
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.
Huang Y; Wu Z; Riwanto M; Gao S; Levison BS; Gu X; Fu X; Wagner MA; Besler C; Gerstenecker G; Zhang R; Li XM; DiDonato AJ; Gogonea V; Tang WH; Smith JD; Plow EF; Fox PL; Shih DM; Lusis AJ; Fisher EA; DiDonato JA; Landmesser U; Hazen SL
J Clin Invest; 2013 Sep; 123(9):3815-28. PubMed ID: 23908111
[TBL] [Abstract][Full Text] [Related]
3. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.
May-Zhang LS; Yermalitsky V; Huang J; Pleasent T; Borja MS; Oda MN; Jerome WG; Yancey PG; Linton MF; Davies SS
J Biol Chem; 2018 Jun; 293(24):9176-9187. PubMed ID: 29712723
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional High-density Lipoprotein: The Role of Myeloperoxidase and Paraoxonase-1.
Bacchetti T; Ferretti G; Carbone F; Ministrini S; Montecucco F; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2021; 28(14):2842-2850. PubMed ID: 32674726
[TBL] [Abstract][Full Text] [Related]
5. Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.
Huang J; Yancey PG; Tao H; Borja MS; Smith LE; Kon V; Davies SS; Linton MF
Nutrients; 2020 Jun; 12(7):. PubMed ID: 32629758
[TBL] [Abstract][Full Text] [Related]
6. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein dysfunction in carotid artery stenosis.
Senat A; Ilker Yon M; Yuce G; Deniz O; Erel O
Vasa; 2023 Sep; 52(5):342-348. PubMed ID: 37622201
[No Abstract] [Full Text] [Related]
8. Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
Emami Razavi A; Basati G; Varshosaz J; Abdi S
Acta Med Iran; 2013 Jul; 51(6):365-71. PubMed ID: 23852840
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase 1 and HDL maturation.
Gugliucci A; Menini T
Clin Chim Acta; 2015 Jan; 439():5-13. PubMed ID: 25261854
[TBL] [Abstract][Full Text] [Related]
11. Clusterin, paraoxonase 1, and myeloperoxidase alterations induce high-density lipoproteins dysfunction and contribute to peripheral artery disease; aggravation by type 2 diabetes mellitus.
Sanda GM; Toma L; Barbalata T; Moraru OE; Niculescu LS; Sima AV; Stancu CS
Biofactors; 2022 Mar; 48(2):454-468. PubMed ID: 34741558
[TBL] [Abstract][Full Text] [Related]
12. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
[TBL] [Abstract][Full Text] [Related]
13. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies.
Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M
Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772
[TBL] [Abstract][Full Text] [Related]
14. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.
Rosenblat M; Gaidukov L; Khersonsky O; Vaya J; Oren R; Tawfik DS; Aviram M
J Biol Chem; 2006 Mar; 281(11):7657-65. PubMed ID: 16407304
[TBL] [Abstract][Full Text] [Related]
15. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.
Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM
Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of dysfunctional high-density lipoprotein levels with myeloperoxidase/paraoxonase-1 ratio in rheumatoid arthritis.
Alisik T; Alisik M; Nacir B; Ayhan FF; Genc H; Erel O
Int J Clin Pract; 2021 Jul; 75(7):e14172. PubMed ID: 33756027
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
Malle E; Marsche G; Panzenboeck U; Sattler W
Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
[TBL] [Abstract][Full Text] [Related]
18. Lyso-DGTS lipid isolated from microalgae enhances PON1 activities in vitro and in vivo, increases PON1 penetration into macrophages and decreases cellular lipid accumulation.
Dahli L; Atrahimovich D; Vaya J; Khatib S
Biofactors; 2018 May; 44(3):299-310. PubMed ID: 29659105
[TBL] [Abstract][Full Text] [Related]
19. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
Soran H; Schofield JD; Liu Y; Durrington PN
Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
[TBL] [Abstract][Full Text] [Related]
20. The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
Variji A; Shokri Y; Fallahpour S; Zargari M; Bagheri B; Abediankenari S; Alizadeh A; Mahrooz A
Atherosclerosis; 2019 Jan; 280():7-13. PubMed ID: 30448568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
